A single centre experience with CytoSorb® as an adjunct therapy in critically ill patients with sepsis: a case series
Objective: Sepsis is an immune response to infections that are caused by bacteria, viruses, fungi, or parasites. This potentially life-threatening condition is associated with high mortality and morbidity that causes a major global health burden and hence requires intense therapeutic support and clo...
Main Authors: | H. Gajera, S. Gohil, A. Chhatravala |
---|---|
Format: | Article |
Language: | English |
Published: |
Verduci Editore
2023-06-01
|
Series: | International Journal of Medical Device and Adjuvant Treatments |
Subjects: | |
Online Access: | https://www.ijmdat.com/wp-content/uploads/sites/3/2023/06/e398.pdf |
Similar Items
-
Hemoadsorption by CytoSorb in septic patients: a case series
by: Klaus Kogelmann, et al.
Published: (2017-03-01) -
Hemoadsorption with CytoSorb shows a decreased observed versus expected 28-day all-cause mortality in ICU patients with septic shock: a propensity-score-weighted retrospective study
by: Willem Pieter Brouwer, et al.
Published: (2019-09-01) -
Adjunctive Hemoadsorption Therapy with CytoSorb in Patients with Septic/Vasoplegic Shock: A Best Practice Consensus Statement
by: Steffen Mitzner, et al.
Published: (2023-11-01) -
Hemoadsorption with CytoSorb in Septic Shock Reduces Catecholamine Requirements and In-Hospital Mortality: A Single-Center Retrospective ‘Genetic’ Matched Analysis
by: Christopher Rugg, et al.
Published: (2020-11-01) -
Impact of CytoSorb Hemoadsorption Therapy on Fluid Balance in Patients with Septic Shock
by: Klaus Kogelmann, et al.
Published: (2024-01-01)